Latest Health News
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell…
Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise…
Defeating the “Cold Chain” Barrier: Bio Usawa and Nanoly Bioscience Announce Strategic $500 Million Licensing Agreement for Breakthrough DynaShield Technology
SAN FRANCISCO and LOS ANGELES and KIGALI, Rwanda, Feb. 17, 2026 (GLOBE…
HCW Biologics Announces Pricing of $1.5 Million Follow-On OfferingPriced At-The-Market Under NASDAQ Rules
MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 17, 2026 18:22 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Oculis Appoints Katie Kazem as Chief Legal Officer
Ms. Kazem brings extensive and global expertise in corporate governance and securities…
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board
HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled…
